Hers Skincare LegitScript and Accreditation Status: What Women Need to Know Before Ordering

What LegitScript Certification Actually Means for Online Pharmacies

LegitScript certification is the clearest third-party signal that an online pharmacy or telehealth platform dispensing medications meets U.S. Legal and safety standards. It is not a government license, but major payment networks and Google require it for pharmacies that want to advertise or process payments. LegitScript's verification program checks that a pharmacy holds valid state licenses, dispenses only with valid prescriptions, and does not sell controlled or counterfeit drugs. The absence of certification does not automatically mean a pharmacy is illegal. It does mean you have fewer independent guarantees.

Why This Matters Specifically for Women Seeking Prescription Skincare

Women ordering prescription skincare online are typically seeking ingredients such as tretinoin, hydroquinone, or azelaic acid. Tretinoin is a Schedule-uncontrolled but prescription-only vitamin A derivative with a well-documented teratogenicity profile. The FDA's drug label for tretinoin topical notes that although systemic absorption from topical use is low, the drug is classified Pregnancy Category X in some formulations and carries a clear contraindication in pregnancy across all topical retinoid classes.

For women who are pregnant, trying to conceive, or even postpartum and not yet using reliable contraception, ordering tretinoin from any online platform without a thorough intake process creates real clinical risk. A platform's accreditation status is one proxy for how carefully that intake process filters out contraindicated patients.

Hers and LegitScript: The Current Picture

As of January 2025, a search of the LegitScript verified pharmacy database does not return Hers or its parent entity Fo Labs Inc. As a certified online pharmacy or telehealth provider. This differs from platforms such as Ro (Roman Health) and some GoodRx-affiliated pharmacies that carry active LegitScript certification.

The absence of LegitScript verification for Hers does not, on its own, mean the platform is dispensing illegally. Hers states it works with licensed U.S. Pharmacies. You should independently verify the dispensing pharmacy name on your shipping label, then confirm its license in your state through the NABP drug store database or your state pharmacy board website.

How Hers Skincare Works: The Platform Model

Hers uses an asynchronous, photo-based telehealth model. You submit photos of your skin and answer a questionnaire. A licensed clinician (usually a nurse practitioner or physician assistant) reviews your intake and, if appropriate, sends a prescription to a partner pharmacy. The product ships directly to your door.

What the Model Gets Right

The async model works reasonably well for stable, straightforward dermatological concerns such as mild-to-moderate acne or early photoaging in otherwise healthy adults. It removes the barrier of scheduling a dermatology appointment, which the American Academy of Dermatology notes can involve waits of several weeks to months in underserved areas. For women in reproductive years managing hormonal acne tied to their menstrual cycle, faster access to a retinoid or topical antibiotic can matter.

Where the Model Falls Short

Photo-based async visits have a documented limitation: they cannot capture a full medication history, a nuanced pregnancy intention discussion, or the subtle skin findings that change clinical decision-making. A 2020 study in JAMA Dermatology found that teledermatology diagnostic accuracy varied significantly depending on image quality and the thoroughness of the intake questionnaire, with async visits performing below synchronous video visits for conditions requiring clinical pattern recognition.

Hers does not publicly disclose the full scope of its clinical intake process. Whether it routinely screens for current pregnancy, breastfeeding status, or planned pregnancy before dispensing tretinoin is not confirmed in any publicly available documentation reviewed for this article.

Prescription Ingredients in Hers Formulations: A Women's-Health Breakdown

Hers offers several skincare formulations. Most are combination products created by a compounding pharmacy to Hers specifications. The active ingredients commonly included are tretinoin (typically 0.01% to 0.05%), hydroquinone (2% to 4%), azelaic acid (up to 20%), niacinamide, and various stabilizing agents.

Tretinoin

Tretinoin is the best-studied topical retinoid for photoaging and acne. A 1995 trial in the New England Journal of Medicine demonstrated statistically significant improvement in fine wrinkling at 0.05% concentration over 10 months compared to vehicle. The drug works by binding retinoic acid receptors in keratinocytes, accelerating cell turnover and stimulating collagen synthesis.

Perimenopausal and postmenopausal women: Estrogen decline reduces skin thickness and sebaceous gland activity. Skin is drier and more easily irritated by retinoids at standard doses. Women in perimenopause often need to start at 0.01% to 0.025% and increase slowly, and they may need more emollient support than is built into standard formulations. If you are in this life stage and using Hers, the one-size-fits-all compounded cream may not be optimized for your skin's lower tolerance threshold.

Women with PCOS: Hyperandrogenism in PCOS drives sebaceous gland activity and comedonal acne that often persists well past the teens. Tretinoin is appropriate here, but the most effective management also typically involves addressing the androgen excess systemically, which a skin-only telehealth platform is not designed to do. ACOG Practice Bulletin No. 194 on PCOS recommends a multidisciplinary approach that includes treating the underlying hormonal driver, not just the surface manifestation.

Hydroquinone

Hydroquinone at 4% is prescription-strength and inhibits tyrosinase, reducing melanin synthesis. It is effective for melasma, post-inflammatory hyperpigmentation from hormonal acne, and periorbital darkening. The FDA has debated hydroquinone's OTC status since 2006 and has never finalized a ruling either approving or banning it at OTC concentrations, leaving 2% OTC products in legal gray territory and 4% firmly prescription-only.

Pregnancy and melasma: Melasma is extremely common in pregnancy (affecting an estimated 50% to 70% of pregnant women, per ACOG). Women are sometimes tempted to order Hers or similar products to treat pregnancy melasma. Hydroquinone is absorbed systemically to a measurable degree. Safety in pregnancy has not been established and most clinicians advise avoiding it during pregnancy and lactation. Azelaic acid 20% is a safer alternative with a better evidence profile for use during pregnancy and is classified FDA Pregnancy Category B.

Azelaic Acid

Azelaic acid 20% (prescription-strength Finacea gel) is one of the few anti-acne and anti-pigmentation agents considered acceptable in pregnancy based on limited systemic absorption data. It is often the preferred option for pregnant or breastfeeding women with active acne or melasma. This is one area where the Hers formulary, if it includes azelaic acid, could offer genuine clinical value to this population, provided the prescribing clinician has confirmed pregnancy or lactation status and adjusted the formula accordingly.

Pregnancy, Lactation, and Contraception: What Every Woman Ordering Prescription Skincare Must Know

This section is required reading before you place any order for prescription skincare from any online platform, Hers or otherwise.

Tretinoin in Pregnancy: Contraindicated

Topical tretinoin is contraindicated in pregnancy. The systemic absorption of topical tretinoin is low but not zero. A pharmacokinetic study cited in the FDA prescribing information found measurable plasma levels of tretinoin and its metabolites after topical application, with levels influenced by skin condition, formulation vehicle, and application area. Case reports have linked first-trimester exposure to oral retinoids with craniofacial, cardiac, and central nervous system defects. Topical retinoids are not expected to carry equivalent risk, but because the risk cannot be fully quantified, avoidance in pregnancy is the standard clinical recommendation.

If you are trying to conceive, use reliable contraception while on tretinoin. Stop tretinoin as soon as you know you are pregnant and contact your OB-GYN or midwife.

Hydroquinone in Pregnancy: Insufficient Data, Avoid

Measurable systemic absorption has been documented. A 2019 literature review in the Journal of the American Academy of Dermatology concluded that available human data are insufficient to establish safety, and that most dermatologists advise discontinuation during pregnancy. Azelaic acid should replace hydroquinone in pregnant patients who need treatment for melasma or hyperpigmentation.

Lactation

Tretinoin's transfer into breast milk following topical application has not been systematically studied. Given the low but nonzero systemic absorption and the known developmental sensitivity of neonates to retinoids, most lactation medicine specialists advise caution. If you are breastfeeding and want to use a retinoid, discuss the risk-benefit with your OB-GYN or a LactMed-listed lactation consultant before ordering online.

What Hers Should Be Doing at Intake, and What to Ask

Any responsible platform dispensing tretinoin or hydroquinone should:

• Directly ask whether you are pregnant, trying to conceive, or breastfeeding before issuing a prescription.
• Document your contraceptive method if you are of reproductive age.
• Decline to prescribe tretinoin or hydroquinone to patients who are pregnant or planning pregnancy without an adequate contraceptive plan.

If you use Hers, review your intake questionnaire carefully. If you were not asked these questions, that is a meaningful safety gap.

BBB Standing and Consumer Complaints

The Better Business Bureau profile for Fo Labs Inc. (the parent company of Hers and Hims) shows a history of consumer complaints. The most common complaint themes visible in publicly filed BBB records include:

• Difficulty canceling subscription orders.
• Charges continuing after cancellation requests.
• Delays in prescription processing or shipment.
• Difficulty reaching a human clinician for follow-up questions.

The BBB accreditation status and complaint count change over time. Before ordering, check the current rating directly at bbb.org by searching "Fo Labs Inc." or "Hims Hers."

These complaints are not evidence that Hers is dispensing unsafe medications. They are evidence that subscription management and customer service have been friction points for a meaningful number of women. For prescription skincare, where follow-up access to your prescribing clinician matters clinically, persistent customer-service difficulties carry more weight than they would for a non-prescription brand.

Who This Is Right For, and Who Should Look Elsewhere

This framework is original to WomanRx. Use it to place yourself before ordering from Hers or any similar async prescription skincare platform.

Women Who May Find Hers Reasonable

• You are between 18 and 45, not pregnant, not breastfeeding, and not actively trying to conceive.
• You use reliable contraception (combined oral contraceptive, IUD, implant, or other highly effective method) consistently.
• Your concern is mild-to-moderate acne or early photoaging on otherwise healthy, non-sensitized skin.
• You have no history of kidney disease, significant rosacea, or active eczema that would alter retinoid tolerance.
• You understand you are getting an async consultation and will need to monitor your own skin closely in the first 6 to 12 weeks.
• You are not perimenopausal or postmenopausal with severe skin atrophy, where standard formulations may cause more irritation than benefit.

Women Who Should Seek a Different Route

• You are pregnant, possibly pregnant, or trying to conceive. Do not order tretinoin or hydroquinone from any platform.
• You are breastfeeding and want a retinoid. Consult your OB-GYN or a board-certified dermatologist first.
• You have moderate-to-severe melasma driven by estrogen or pregnancy hormones. You need hormonal context, not just topical treatment.
• You have PCOS with persistent adult acne. Treating skin only, without addressing androgen excess, is partial management. An endocrinologist or OB-GYN familiar with PCOS should be part of your care.
• You are perimenopausal or postmenopausal with thin, dry, sensitized skin. A dermatologist who can examine you in person and calibrate the retinoid dose to your current skin barrier status will get you better results with less irritation.
• You have had allergic or inflammatory reactions to prior retinoid use.
• You need a video visit or in-person exam before feeling confident starting a prescription product.

State Pharmacy Licensure and How to Verify Independently

The dispensing pharmacy for Hers products is typically listed on your prescription label. Your state pharmacy board website allows you to verify whether that pharmacy holds an active license to ship to your state. The NABP's Verified Pharmacy Program is another independent check.

If the pharmacy dispensing your Hers prescription is a 503A compounding pharmacy (which many custom skincare compounders are), its oversight differs from a traditional retail pharmacy. FDA oversight of 503A compounders is complaint-driven rather than proactive. This means the burden of safety monitoring shifts more to the prescribing platform and the patient than it would with a commercially manufactured, FDA-approved drug.

Ask Hers directly:

• What is the name of the dispensing pharmacy?
• Is the dispensing pharmacy a 503A compounder or a licensed retail pharmacy?
• Is the pharmacy licensed in my state?

If you do not get a clear answer, that tells you something important.

What Independent and Peer-Reviewed Evidence Says About Async Teledermatology for Women

The evidence base for teledermatology is growing but uneven. A 2021 systematic review in the British Journal of Dermatology found that teledermatology was non-inferior to in-person care for follow-up management of established diagnoses, but showed lower diagnostic accuracy for new presentations where differential diagnosis was complex. For women whose skin concern is straightforward comedonal acne with no rosacea overlay, the evidence is more supportive of async care. For women with melasma modified by hormonal shifts across the menstrual cycle or perimenopause, the diagnostic nuance that teledermatology can miss is clinically consequential.

A 2022 paper in the Journal of Women's Health noted that women are disproportionately affected by melasma (female-to-male ratio approximately 9:1) and that hormonal triggers are the dominant driver in most cases. Treating melasma without addressing the hormonal context, as an async skincare platform necessarily does, addresses only part of the problem.

The evidence gap on women specifically is real. Most teledermatology validation studies have not stratified outcomes by hormonal status, menstrual cycle phase, or menopausal stage. This limits confidence in applying their aggregate findings to perimenopausal or postmenopausal women using the same platforms studied primarily in younger adults.

Red Flags to Watch For With Any Online Prescription Skincare Platform

These apply to Hers and every competitor:

• No direct question about pregnancy or contraception before dispensing tretinoin or hydroquinone.
• Prescription issued within minutes of submitting photos, with no visible clinical review step.
• No named prescribing clinician listed on the prescription label.
• Dispensing pharmacy not licensed in your state.
• No refund or pause mechanism if you become pregnant after starting treatment.
• Customer service unreachable when you have a clinical question about a reaction.

If you experience an adverse reaction to any prescription skincare product dispensed online, report it to MedWatch, the FDA's safety reporting program.